Item 2.01
Completion of Acquisition or Disposition of Assets.

As previously disclosed, on August 5, 2023, Tabula Rasa HealthCare, Inc. ("TRHC" or the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Locke Buyer, LLC, a Delaware limited liability company ("Parent"), and Locke Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), which provides for the merger of Merger Sub with and into the Company with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger").

On November 3, 2023, on the terms and subject to the conditions set forth in the Merger Agreement and pursuant to and in accordance with the applicable provisions of the Delaware General Corporation Law (the "DGCL"), the Merger was consummated. At the effective time of the Merger, Parent completed its previously announced acquisition of the Company and the Company became a wholly owned subsidiary of Parent.

The foregoing description of the Merger Agreement and the transactions contemplated thereby is not complete and is subject to and qualified in its entirety by reference to the Merger Agreement, which was filed as Exhibit 2.1 to the Company's Current Report on Form 8-K filed with the SEC on August 7, 2023, the terms of which are incorporated herein by reference, and the effects of the Merger and the other transactions contemplated by the Merger Agreement will be further described in a subsequent filing on Form 8-K.

Attachments

Disclaimer

Tabula Rasa HealthCare Inc. published this content on 03 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 November 2023 13:23:46 UTC.